EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting ADAR1 Restores Interferon Signaling and Enhances Immunotherapy Response in Multiple Myeloma

Songze Leng, Yaoyao Tian, Yao Liu, Weiwei Zhao, Wei Wang iD

International Journal of Molecular Sciences · 24.07.2026 · 27 (15) · 6602

DOI: 10.3390/ijms27156602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.07.2026. Verfasst von Songze Leng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Hauptthemen laut MEDLINE: Adenosine Deaminase, Multiple Myeloma, RNA-Binding Proteins, Signal Transduction. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hei-longjiang Province, a transvers research project funded by the Bei jing Huikang Charity Foundation, Beijing Huikang Charity Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) remains an incurable hematological malignancy in which tumor-intrinsic immune evasion limits the efficacy of immunotherapy. Here, we identify the RNA editing enzyme ADAR1 as a key regulator of innate immune suppression in MM. Integrative analyses of bulk and single-cell transcriptomic datasets, together with clinical validation, demonstrated that ADAR1 is upregulated in malignant plasma cells and is associated with adverse clinical outcomes and reduced CD8+ T-cell infiltration. Mechanistically, ADAR1 knockdown increased the association of endogenous dsRNA with melanoma differentiation-associated protein 5 (MDA5), restoring type I interferon (IFN) signaling, enhancing IFNα production and STAT1 activation, and promoting CD8+ T-cell proliferation and cytotoxic function. These effects were largely abolished by MDA5 depletion, establishing a functional ADAR1–MDA5 signaling axis in MM. In vivo, treatment with 8-azaadenosine significantly potentiated the antitumor efficacy of PD-1 blockade, resulting in reduced tumor growth, increased tumor cell apoptosis, elevated IFNα expression, and enhanced CD8+ T-cell infiltration. Together, our findings demonstrate that ADAR1-mediated RNA editing enables immune evasion by restricting MDA5-dependent sensing of endogenous dsRNA and highlight the ADAR1–MDA5-type I interferon axis as a promising therapeutic target for improving immunotherapy in multiple myeloma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine DeaminaseMultiple MyelomaRNA-Binding ProteinsSignal TransductionImmunotherapyHumansInterferon-Induced Helicase, IFIH1AnimalsCD8-Positive T-LymphocytesCell Line, TumorMiceRNA EditingInterferon-alphaGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ADAR1CD8+ T cellsIFNαMDA5multiple myeloma

Substanzen

Adenosine DeaminaseRNA-Binding ProteinsInterferon-Induced Helicase, IFIH1IFIH1 protein, humanADAR protein, humanInterferon-alpha

Autor:innen und Institutionen

  • Department of Hematology, Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
  • Department of Cell Biology, School of Basic Medicine, Harbin Medical University, Harbin 150081, China.

ORCID-Profile: Wei Wang

Förderung

  • Natural Science Foundation of Hei-longjiang Province
  • a transvers research project funded by the Bei jing Huikang Charity Foundation
  • Beijing Huikang Charity Foundation
  • Beijing Health Promotion Association

Zitieren

APA

Leng, S., Tian, Y., Liu, Y., Zhao, W., & Wang, W. (2026). Targeting ADAR1 Restores Interferon Signaling and Enhances Immunotherapy Response in Multiple Myeloma. International Journal of Molecular Sciences, 27(15), 6602. https://doi.org/10.3390/ijms27156602

Vancouver

Leng S, Tian Y, Liu Y, Zhao W, Wang W. Targeting ADAR1 Restores Interferon Signaling and Enhances Immunotherapy Response in Multiple Myeloma. International Journal of Molecular Sciences. 2026;27(15):6602. doi:10.3390/ijms27156602

BibTeX
@article{Leng2026,
  author = {Leng, Songze and Tian, Yaoyao and Liu, Yao and Zhao, Weiwei and Wang, Wei},
  title = {Targeting ADAR1 Restores Interferon Signaling and Enhances Immunotherapy Response in Multiple Myeloma},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6602},
  doi = {10.3390/ijms27156602}
}
Kostenlos starten →